This consensus document provides best practice guidelines for balancing ischemic and bleeding risks in AF patients requiring antithrombotic therapy for ACS or PCI.
Expert consensus guides antithrombotic choices balancing ischemic and bleeding risks in AF with ACS/PCI; leaves open need for new trial data.
There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis, and the risk of bleeding. This consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients.
No takes yet. Share an insight, caveat, or question.
Huber et al. (2009) studied Atrial Fibrillation and Acute Coronary Syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: